Striking a balance between artificial intelligence innovation and regulation is crucial for leveraging its benefits while safeguarding against risks. On this episode, I’m joined by Congressman Buddy Carter, U.S. Representative for Georgia's 1st District, to explore the complexities of AI regulation and its impact on healthcare and other sectors. Key Takeaways: (01:48) President Biden's Executive Order on AI aims to set new standards. (04:34) AI's potential in healthcare, including telehealth and drug development. (05:47) Legal implications for doctors not using available AI technologies. (07:55) AI could speed up the drug development process. (10:52) The need for constantly updated AI standards. (11:56) Debate on creating a separate regulatory body for AI. (14:03) Importance of including diverse voices in AI regulation. (16:57) Federal preemption of state and local AI laws to avoid regulatory patchwork. Resources Mentioned: Buddy Carter - https://www.linkedin.com/in/buddycarterga/ President Biden's Executive Order on AI - https://www.whitehouse.gov/briefing-room/presidential-actions/2023/10/30/executive-order-on-the-safe-secure-and-trustworthy-development-and-use-of-artificial-intelligence/ EU AI Act - https://www.europarl.europa.eu/topics/en/article/20230601STO93804/eu-ai-act-first-regulation-on-artificial-intelligence Section 230 of the Communications Decency Act - https://www.eff.org/issues/cda230 Thanks for listening to the Regulating AI: Innovate Responsibly podcast. If you enjoyed this episode, please leave a 5-star review to help get the word out about the show. And be sure to subscribe so you never miss another insightful conversation. #AIRegulation #AISafety #AIStandard